Longeveron ® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer's Disease at the Alzheimer's Association International Conference ® (AAIC)

Posted from: this blog via Microsoft Power Automate.